MANSERVIGI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 6245
EU - Europa 1889
AS - Asia 1104
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
AF - Africa 1
Totale 9251
Nazione #
US - Stati Uniti d'America 6241
CN - Cina 762
UA - Ucraina 578
GB - Regno Unito 318
TR - Turchia 307
DE - Germania 266
IT - Italia 185
SE - Svezia 139
PL - Polonia 133
FI - Finlandia 116
AT - Austria 51
BE - Belgio 44
FR - Francia 32
IR - Iran 14
KR - Corea 7
RU - Federazione Russa 7
BR - Brasile 4
CA - Canada 4
IN - India 4
NL - Olanda 4
RO - Romania 4
ES - Italia 3
EU - Europa 3
VN - Vietnam 3
AU - Australia 2
DK - Danimarca 2
LI - Liechtenstein 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
ID - Indonesia 1
IL - Israele 1
MA - Marocco 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TH - Thailandia 1
VE - Venezuela 1
Totale 9251
Città #
Woodbridge 891
Fairfield 841
Jacksonville 619
Houston 590
Chandler 504
Ann Arbor 458
Wilmington 331
Seattle 328
Ashburn 303
Cambridge 282
Nanjing 194
Beijing 192
Izmir 188
Princeton 134
Warsaw 133
San Diego 87
Boardman 59
Shenyang 58
Milan 51
Vienna 51
Nanchang 47
Brussels 44
Hebei 38
Tianjin 38
Jiaxing 37
San Mateo 34
Ferrara 28
Changsha 26
Jinan 23
Ningbo 23
Norwalk 20
Falls Church 19
Philadelphia 19
Mountain View 17
Dearborn 15
Kunming 15
Leawood 15
Auburn Hills 14
Augusta 14
Orange 12
Guangzhou 11
Redwood City 11
Taizhou 11
Zhengzhou 11
Ardabil 10
Verona 10
Los Angeles 8
Monmouth Junction 8
Des Moines 7
Indiana 7
Bologna 6
Bremen 6
Hangzhou 6
London 6
Washington 6
Addison 5
Haikou 5
Helsinki 5
Lanzhou 5
Changchun 4
Bari 3
Chicago 3
Dong Ket 3
Napoli 3
Amsterdam 2
Düsseldorf 2
Genoa 2
New York 2
Paris 2
Rome 2
Roseto Degli Abruzzi 2
Taiyuan 2
Toronto 2
Vanzago 2
Alcalá De Henares 1
Allahabad 1
Andover 1
Aprilia 1
Auckland 1
Bangalore 1
Belgrade 1
Brookline 1
Brugg 1
Buffalo 1
Büdelsdorf 1
Capannori 1
Catanzaro 1
Chisinau 1
Chongqing 1
Como 1
Cuneo 1
Frankfurt am Main 1
General Trias 1
Genova 1
Groningen 1
Guardiagrele 1
Hefei 1
Hicksville 1
Hunedoara 1
Isfahan 1
Totale 6998
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors. 183
null 179
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 143
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 125
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 124
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 119
Herpes Simplex Virus Growth, Preparation, and Assay 119
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 118
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 115
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 112
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 110
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 109
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 108
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 108
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 107
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 107
null 107
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)]. 106
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 106
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 105
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 105
null 104
null 104
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 104
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 102
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 102
Herpesvirus/retrovirus chimeric vectors 101
Replication-competent herpes simplex vectors: design and applications 100
null 99
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 99
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 99
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 98
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 98
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 98
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 97
Purinergic Signaling: A New Pharmacological Target Against Viruses? 96
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 95
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 95
null 95
HSV as a vector in vaccine development and gene therapy 94
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 94
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 93
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 91
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 91
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 91
HSV as a vector in vaccine development and gene therapy 91
null 89
MEMBRANE PROTEIN PATTERN IN HEREDITARY SPHEROCYTOSIS IN FIVE SUBJECTS FROM NORTH-EAST ITALY OBTAINED BY SDS-PAGE USING N,N'-DIALLYLTARTARDIAMIDE 88
null 88
null 88
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses. 87
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 87
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 86
null 83
State of viral DNA in BK virus-transformed rabbit cells 83
HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) URACIL-DNA GLYCOSYLASE - FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI, BIOCHEMICAL-CHARACTERIZATION, AND SELECTIVE-INHIBITION BY 6-(P-N-OCTYLANILINO)URACIL 82
null 81
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 80
null 80
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 80
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 80
Virus erpetici come vettori vaccinali 80
HSV-1 virions engineered for specific binding to cell surface receptors 79
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 77
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 77
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 76
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 76
Capitolo 55 Retrovirus 73
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 71
Molecular diagnosis of herpes simplex encephalitis 71
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 70
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 69
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 65
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 63
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 63
CELL-TYPE DEPENDENT SENSITIVITY OF HERPES-SIMPLEX-VIRUS-1 MUTANTS TO PLAQUE DEVELOPMENT INHIBITION BY AN ANTI-GD MONOCLONAL-ANTIBODY 61
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 59
Niosomes containing HSV immunogens as possible vaccine against genital herpes 59
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 58
EXPRESSION OF THE HERPES-SIMPLEX VIRUS TYPE-1 GLYCOPROTEIN-E IN HUMAN-CELLS AND IN ESCHERICHIA-COLI - PROTECTION STUDIES AGAINST LETHAL VIRAL-INFECTION IN MICE 58
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 57
Transformation by defined regions of herpes simplex virus DNA. 56
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 56
Ocular disease patterns caused by genetically related mutants of Herpes simplex virus type 1. 56
Intranasal immunization with non-ionic surfactant vescicles containing a secreted recombinant form of gB protein confers protective immunity against genital herpes in mice 55
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 55
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 54
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 53
The expression of immediate early genes of herpes simplex virus type 1 contributes to the neuroplasticity induced by viral infection on the enteric nervous system 53
Niosomes for vaginal administration of an antiherpetic peptide 52
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 52
null 51
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 50
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 50
null 49
Sequences homologous to two separate transforming regions of herpes simplex virus DNA are linked in two genital tumors 48
Virus vectors for immunoprophylaxis 47
Molecular analysis of behavior by gene transfer into neurons with herpes simplex vectors 47
Gene therapy of the nervous system by herpes virus vectors 47
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 47
Totale 8548
Categoria #
all - tutte 16830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 957
Totale 17787


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201892 0000 00 00 117272
2018/20191476 8121170 1914 15629 118234267538
2019/20202301 4017994327 142232 180244 14823817640
2020/20211461 13612469152 66173 65175 2417522775
2021/20221407 581378683 7648 7065 5691124513
2022/20231088 1314864149 176186 70118 146000
Totale 9343